How Does Botox Treat PSP Symptoms?
At a Glance
Botox injections are an effective medical treatment for two common Progressive Supranuclear Palsy (PSP) symptoms: excessive drooling and involuntary eye closing. By relaxing targeted eyelid muscles or reducing salivary gland production, Botox can significantly improve daily comfort and independence.
In this answer
3 sections
While you might associate Botox with cosmetic procedures, it is actually a highly effective, evidence-based medical treatment for several frustrating symptoms of Progressive Supranuclear Palsy (PSP). When your neurologist suggests Botulinum toxin (best known by the brand name Botox), they are recommending it to improve your daily function and quality of life. In PSP, these injections are most commonly used to treat excessive drooling (sialorrhea) and involuntary eye closing (blepharospasm or eyelid opening apraxia) [1][2].
Managing Excessive Drooling (Sialorrhea)
Excessive drooling is a common symptom in atypical parkinsonian syndromes like PSP [3]. It happens not because you are producing too much saliva, but because the muscles used for swallowing become slower and less coordinated.
Botulinum toxin can be injected directly into the salivary glands (the parotid and submandibular glands) to reduce the amount of saliva your body produces [4]. By temporarily blocking the chemical signals to these glands, the injections decrease saliva flow, making it easier for your swallowing muscles to keep up.
Safety and Precision: Because people with PSP often already have difficulty swallowing (dysphagia), there is a risk that the toxin could spread to nearby swallowing muscles and make swallowing harder [5][6]. To minimize this risk, doctors often use ultrasound guidance to ensure the injection goes exactly into the salivary glands [7][8]. This approach is generally considered safe and effective for long-term management [1].
Keeping the Eyes Open
PSP can cause significant problems with your eyelids, making it difficult to keep your eyes open and severely impacting your ability to see and read. There are two main eyelid issues that Botulinum toxin can help address:
- Blepharospasm: This is an involuntary, forceful squeezing shut of the eyelid muscles. Botulinum toxin is a recognized and highly effective treatment for this condition [2]. By relaxing the overactive muscles, it prevents the forceful squeezing and allows you to keep your eyes open.
- Apraxia of Eyelid Opening (AEO): This is a difficulty in initiating the movement to lift the eyelids, even when there is no forceful squeezing [9]. Your brain has trouble sending the right signal to the eyelid muscles to open them. While AEO can be more challenging to treat than blepharospasm, targeted Botulinum toxin injections can still be beneficial [2]. Doctors may target specific eyelid muscles (such as the pretarsal orbicularis oculi) to help improve eyelid opening [10].
What to Expect from Treatment
It’s natural to feel anxious about injections near your face and neck. The procedure is performed using very fine needles, which typically cause only a brief pinching sensation.
It is important to understand that Botulinum toxin is a temporary treatment, not a cure, and it does not work instantly.
- Onset and Duration: You will likely not see immediate results before leaving the clinic. It usually takes several days (often 3 to 14 days) for the medication to take full effect. Once working, the benefits typically last for a few months, after which the injections will need to be repeated [11].
- Side Effects: Adverse effects are usually mild and reversible, often resolving within a few weeks [12]. Aside from the risk of worsened swallowing with salivary gland injections, repeated use can occasionally lead to the body forming antibodies that make the treatment less effective over time [13][14]. Eyelid injections can sometimes cause mild bruising or temporary drooping of the eyelid (ptosis), which can make the eye look slightly sleepy [15].
Botulinum toxin in the context of PSP is entirely therapeutic. By directly addressing excessive drooling and eyelid closure, it can significantly improve comfort, safety, and independence.
Common questions in this guide
How does Botox help with excessive drooling in PSP?
Why is ultrasound used during Botox injections for drooling?
Can Botox help if I cannot keep my eyes open due to PSP?
How long does it take for Botox to start working?
How long do the benefits of Botox last for PSP symptoms?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do you use ultrasound guidance when administering injections for drooling to protect my swallowing muscles?
- 2.Based on my symptoms, do I have blepharospasm, apraxia of eyelid opening, or a combination of both?
- 3.How many injections will I need during a typical session, and how long does the appointment take?
- 4.How should we track the effectiveness of the injections, and who do I call if my swallowing seems to worsen?
- 5.Does your office assist with obtaining insurance prior authorization for therapeutic Botulinum toxin injections?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (15)
- 1
SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.
Jost WH, Friedman A, Michel O, et al.
Neurology 2019; (92(17)):e1982-e1991 doi:10.1212/WNL.0000000000007368.
PMID: 30918101 - 2
Use of botulinum toxin in Parkinson's disease.
Jocson A, Lew M
Parkinsonism & related disorders 2019; (59()):57-64 doi:10.1016/j.parkreldis.2018.12.002.
PMID: 30579818 - 3
Sialorrhea in Parkinson's Disease.
Isaacson J, Patel S, Torres-Yaghi Y, Pagán F
Toxins 2020; (12(11)) doi:10.3390/toxins12110691.
PMID: 33142833 - 4
Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.
Hosp C, Naumann MK, Hamm H
Seminars in neurology 2016; (36(1)):20-8 doi:10.1055/s-0035-1571214.
PMID: 26866492 - 5
Dysphagia After Cosmetic Submandibular Gland Botulinum Neurotoxin Type A Injection: A Case Report.
Yang S, Yi YG
Healthcare (Basel, Switzerland) 2026; (14(2)) doi:10.3390/healthcare14020235.
PMID: 41595371 - 6
Negative effects of submandibular botulinum neurotoxin A injections on oral motor function in children with drooling due to central nervous system disorders.
van Hulst K, Kouwenberg CV, Jongerius PH, et al.
Developmental medicine and child neurology 2017; (59(5)):531-537 doi:10.1111/dmcn.13333.
PMID: 27901263 - 7
Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists.
Shariat-Madar B, Chun RH, Sulman CG, Conley SF
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2016; (154(5)):924-7 doi:10.1177/0194599816629612.
PMID: 26908558 - 8
Tolerance of salivary gland botulinum toxin A injection under local anesthesia for the treatment of sialorrhea in children: An observational study.
Toulemonde P, Maltezeanu A, Broucqsault H, Fayoux P
European annals of otorhinolaryngology, head and neck diseases 2022; (139(2)):77-81 doi:10.1016/j.anorl.2021.06.007.
PMID: 34217684 - 9
Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm.
Ferrazzano G, Muroni A, Conte A, et al.
Movement disorders clinical practice 2020; (7(8)):950-954 doi:10.1002/mdc3.13083.
PMID: 33163566 - 10
Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach.
Rayess YA, Awaida CJ, Jabbour SF, et al.
Revue neurologique 2021; (177(1-2)):107-114 doi:10.1016/j.neurol.2020.03.022.
PMID: 32654779 - 11
Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.
Mitsikostas DD, Dekundy A, Hanschmann A, et al.
Current medical research and opinion 2021; (37(10)):1761-1768 doi:10.1080/03007995.2021.1965975.
PMID: 34384301 - 12
Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis.
Hung SA, Liao CL, Lin WP, et al.
Children (Basel, Switzerland) 2021; (8(12)) doi:10.3390/children8121089.
PMID: 34943284 - 13
Immunogenicity of Botulinum Toxin Type A in Different Clinical and Cosmetic Treatment, a Literature Review.
Lee KWA, Chan LKW, Lee AWK, et al.
Life (Basel, Switzerland) 2024; (14(10)) doi:10.3390/life14101217.
PMID: 39459517 - 14
Botulinum Toxin Injection for Hemifacial Spasm and Benign Essential Blepharospasm: A Systematic Review and Meta-Analysis Comparing Pretarsal and Preseptal Injection Techniques.
Noor MA, Abul A, Saleki M, et al.
Aesthetic plastic surgery 2025; (49(13)):3618-3628 doi:10.1007/s00266-025-04913-w.
PMID: 40442495 - 15
Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections.
Yabumoto C, Osaki MH, Osaki T, et al.
Ophthalmic plastic and reconstructive surgery 2023; (39(5)):475-478 doi:10.1097/IOP.0000000000002375.
PMID: 36928309
This page is for informational purposes only and does not replace professional medical advice. Always consult your neurologist to determine if Botulinum toxin injections are safe and appropriate for your specific PSP symptoms.
Get notified when new evidence is published on Progressive supranuclear palsy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.